• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻腔神经内分泌癌对尤文氏肉瘤家族肿瘤的化疗方案有效:一例报告。

NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing's sarcoma family of tumors: a case report.

机构信息

Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.

Department of Head and neck surgery, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.

出版信息

BMC Cancer. 2018 Nov 19;18(1):1134. doi: 10.1186/s12885-018-5087-x.

DOI:10.1186/s12885-018-5087-x
PMID:30453921
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6245604/
Abstract

BACKGROUND

Nuclear protein in testis (NUT) carcinoma (NC) is a rare epithelial malignancy characterized by rearrangement of the NUT gene on chromosome 15. If NC is not suspected, it is often diagnosed as other malignancies. We present the case of NC of the nasal cavity that responded to a chemotherapy regimen for Ewing's sarcoma family of tumors (ESFT).

CASE PRESENTATION

A 49-year-old male presented with epistaxis and pain in the left eye. The patient had a tumor in the left nasal cavity at initial visit and it was biopsied. Firstly, the man was diagnosed with ESFT based on a histopathological examination. The tumor markedly responded to standard cytotoxic chemotherapy for ESFT with distant metastasis. After the start of therapy, a chromosomal analysis revealed an atypical translocation in ESFT and additional immunostaining was positive for anti-NUT antibody. Ultimately, the patient was definitively diagnosed with NC. He received multidisciplinary therapy and symptoms were temporarily relieved. However, he died 9 months after the diagnosis of NC.

CONCLUSIONS

When a pathologically undifferentiated tumor is evident along the midline of the body, NC must be included in the differential diagnosis, and immunohistochemical staining or genetic testing/chromosomal analysis needs to be performed.

摘要

背景

睾丸核蛋白(NUT)癌(NC)是一种罕见的上皮性恶性肿瘤,其特征是 15 号染色体上 NUT 基因的重排。如果不怀疑 NC,通常会被诊断为其他恶性肿瘤。我们报告了一例鼻腔 NC,对尤文氏肉瘤家族肿瘤(ESFT)的化疗方案有反应。

病例介绍

一名 49 岁男性因鼻出血和左眼疼痛就诊。初诊时患者左侧鼻腔有肿瘤,进行了活检。首先,根据组织病理学检查,该男子被诊断为 ESFT。肿瘤对 ESFT 的标准细胞毒性化疗有明显反应,并伴有远处转移。治疗开始后,染色体分析显示 ESFT 存在非典型易位,免疫组织化学染色结果抗 NUT 抗体阳性。最终,该患者被确诊为 NC。他接受了多学科治疗,症状暂时缓解。然而,他在确诊 NC 后 9 个月死亡。

结论

当身体中线有明显的病理未分化肿瘤时,必须将 NC 纳入鉴别诊断,需要进行免疫组织化学染色或基因检测/染色体分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/6c1fcf118f1c/12885_2018_5087_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/a59af787ac76/12885_2018_5087_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/c161253fe97e/12885_2018_5087_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/3e9ccf731550/12885_2018_5087_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/83eebec86865/12885_2018_5087_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/d54e3e2685a9/12885_2018_5087_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/6c1fcf118f1c/12885_2018_5087_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/a59af787ac76/12885_2018_5087_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/c161253fe97e/12885_2018_5087_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/3e9ccf731550/12885_2018_5087_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/83eebec86865/12885_2018_5087_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/d54e3e2685a9/12885_2018_5087_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e2/6245604/6c1fcf118f1c/12885_2018_5087_Fig6_HTML.jpg

相似文献

1
NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing's sarcoma family of tumors: a case report.鼻腔神经内分泌癌对尤文氏肉瘤家族肿瘤的化疗方案有效:一例报告。
BMC Cancer. 2018 Nov 19;18(1):1134. doi: 10.1186/s12885-018-5087-x.
2
Ewing's sarcoma of the cervix, a diagnostic dilemma: a case report and review of the literature.宫颈尤因肉瘤:诊断难题——一例病例报告及文献综述
J Med Case Rep. 2015 Nov 9;9:255. doi: 10.1186/s13256-015-0733-2.
3
NUT midline carcinoma: case report and review of the literature.NUT中线癌:病例报告及文献复习
Int J Surg Pathol. 2011 Dec;19(6):808-12. doi: 10.1177/1066896909353600. Epub 2009 Dec 24.
4
Nuclear protein in testis midline carcinomas: a lethal and underrecognized entity.睾丸中线癌中的核蛋白:一种致命且未被充分认识的实体。
Arch Pathol Lab Med. 2011 Nov;135(11):1494-8. doi: 10.5858/arpa.2010-0389-CR.
5
[Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy].92例尤因肉瘤家族性肿瘤多学科综合治疗的疗效与生存分析
Ai Zheng. 2009 Dec;28(12):1304-9. doi: 10.5732/cjc.008.10609.
6
[Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].[原发性皮肤尤因肉瘤:诊断与治疗的困境]
Ann Dermatol Venereol. 2011 May;138(5):395-8. doi: 10.1016/j.annder.2010.11.010. Epub 2010 Dec 24.
7
A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.一例罕见的鼻腔NUT中线癌日本病例:免疫组化和基因分析的病例报告
Pathol Res Pract. 2014 Jun;210(6):383-8. doi: 10.1016/j.prp.2014.01.013. Epub 2014 Feb 22.
8
[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].[NUT基因表达及重排在诊断上呼吸道NUT中线癌中的应用]
Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):519-24. doi: 10.3760/cma.j.issn.0529-5807.2012.08.003.
9
A 47-year-old woman with nuclear protein in testis midline carcinoma masquerading as a sinus infection: a case report and review of the literature.一名47岁伪装成鼻窦感染的睾丸中线核蛋白癌女性病例报告及文献复习
J Med Case Rep. 2019 Mar 11;13(1):57. doi: 10.1186/s13256-019-2015-x.
10
Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.一名30岁女性患有伴t(15;19)及BRD4-NUT融合致癌基因的中线癌,对多西他赛和放疗有反应。
BMC Cancer. 2006 Mar 16;6:69. doi: 10.1186/1471-2407-6-69.

引用本文的文献

1
A case of advanced NUTc of the nasal cavity: case report and review of the literature.一例鼻腔高级别 NUT 中线癌:病例报告及文献复习
Discov Oncol. 2025 Jul 26;16(1):1415. doi: 10.1007/s12672-025-03227-2.
2
Consolidation immunotherapy following concurrent chemoradiotherapy in a patient with sinonasal NUT carcinoma: a case report.鼻窦 NUT 癌患者同步放化疗后巩固性免疫治疗:一例报告
Front Oncol. 2024 Dec 6;14:1368187. doi: 10.3389/fonc.2024.1368187. eCollection 2024.
3
Therapeutic approaches to sinonasal NUT carcinoma: a systematic review.

本文引用的文献

1
Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach.儿童 NUT 中线癌:采用基于肉瘤的多模式方法治疗成功。
Pediatr Hematol Oncol. 2017 May;34(4):231-237. doi: 10.1080/08880018.2017.1363839. Epub 2017 Oct 17.
2
Renal NUT carcinoma: a case report.肾NUT癌:一例报告
Histopathology. 2018 Feb;72(3):528-530. doi: 10.1111/his.13368. Epub 2017 Nov 7.
3
Nuclear Protein in Testis Midline Carcinoma Presenting in an Infant as a Pericardial Mass with Staging by F-Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography.
治疗鼻窦 NUT 癌的方法:系统评价。
Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3361-3369. doi: 10.1007/s00405-024-08489-0. Epub 2024 Feb 8.
4
Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.鼻窦 NUT 癌的临床病理分子特征:两例报告及文献复习
Front Oncol. 2024 Jan 4;13:1296862. doi: 10.3389/fonc.2023.1296862. eCollection 2023.
5
Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment.NUT 中线癌的长期生存和当前的治疗方法。
Oncologist. 2023 Sep 7;28(9):765-770. doi: 10.1093/oncolo/oyad177.
6
Clinicopathological features and prognostic outcomes of molecularly defined entities in the new edition of the WHO classification of sinonasal carcinoma.新版世界卫生组织鼻窦癌分类中分子定义实体的临床病理特征及预后结果
Front Oncol. 2023 Mar 1;13:1117865. doi: 10.3389/fonc.2023.1117865. eCollection 2023.
7
Sinonasal NUT carcinoma: A retrospective case series from a single institution.鼻窦 NUT 癌:来自单一机构的回顾性病例系列研究。
Front Surg. 2023 Mar 1;10:1098704. doi: 10.3389/fsurg.2023.1098704. eCollection 2023.
8
Case report: NUT carcinoma with MXI1::NUTM1 fusion characterized by abdominopelvic lesions and ovarian masses in a middle-aged female.病例报告:以一名中年女性腹盆腔病变和卵巢肿块为特征的伴有MXI1::NUTM1融合的NUT癌。
Front Oncol. 2023 Jan 11;12:1091877. doi: 10.3389/fonc.2022.1091877. eCollection 2022.
9
Advances in the pathogenesis and treatment of nut carcinoma: a narrative review.坚果癌的发病机制与治疗进展:一篇叙述性综述。
Transl Cancer Res. 2020 Oct;9(10):6505-6515. doi: 10.21037/tcr-20-1884.
10
-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review.- 重新排列的肿瘤 - 一组具有广泛组织学和分子改变的原始肿瘤的异质性群体 - 更新的综述。
Curr Oncol. 2021 Nov 7;28(6):4485-4503. doi: 10.3390/curroncol28060381.
睾丸中线癌中的核蛋白在一名婴儿中表现为心包肿块,并通过氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描进行分期。
World J Nucl Med. 2017 Jul-Sep;16(3):247-250. doi: 10.4103/1450-1147.207284.
4
New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.世界卫生组织头颈部肿瘤分类第4版中的新肿瘤实体:鼻腔、鼻窦和颅底。
Virchows Arch. 2018 Mar;472(3):315-330. doi: 10.1007/s00428-017-2116-0. Epub 2017 Apr 25.
5
Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.携带BRD4-NUT癌蛋白的癌肿对靶向性溴结构域抑制剂OTX015/MK-8628的临床反应
Cancer Discov. 2016 May;6(5):492-500. doi: 10.1158/2159-8290.CD-15-1335. Epub 2016 Mar 14.
6
Sinonasal NUT-Midline Carcinoma - A Multimodality Approach to Diagnosis, Staging and Post-Surgical Restaging.鼻窦NUT中线癌——诊断、分期及术后再分期的多模态方法
Cureus. 2015 Jul 26;7(7):e288. doi: 10.7759/cureus.288. eCollection 2015 Jul.
7
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains.致癌性BRD4-NUT染色质调节因子驱动大拓扑结构域内的异常转录。
Genes Dev. 2015 Jul 15;29(14):1507-23. doi: 10.1101/gad.267583.115.
8
NUT midline carcinoma of the mediastinum showing two types of poorly differentiated tumor cells: a case report and a literature review.纵隔NUT中线癌显示两种低分化肿瘤细胞:一例报告及文献复习
Pathol Res Pract. 2015 Jan;211(1):92-8. doi: 10.1016/j.prp.2014.07.006. Epub 2014 Jul 22.
9
NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.NSD3-NUT 融合癌蛋白在中线 NUT 癌中的作用:对一种新的致癌机制的启示。
Cancer Discov. 2014 Aug;4(8):928-41. doi: 10.1158/2159-8290.CD-14-0014. Epub 2014 May 29.
10
Clinicopathologic features and long-term outcomes of NUT midline carcinoma.NUT 中线癌的临床病理特征和长期预后。
Clin Cancer Res. 2012 Oct 15;18(20):5773-9. doi: 10.1158/1078-0432.CCR-12-1153. Epub 2012 Aug 15.